Live Breaking News & Updates on Elative Share Of Cases

H. Armstrong Roberts / Getty / Katie Martin / The Atlantic
Like many parents, Jason Newland, a pediatrician at Washington University in St. Louis and a dad to three teens ages 19, 17, and 15, now lives in a mixed-vaccination household. His 19-year-old got vaccinated with Johnson & Johnson’s shot two weeks ago and the 17-year-old with Pfizer’s, which is available to teens as young as 16.
The 15-year-old is still waiting for her shot, though a bit impatiently now. “She’s like, ‘Dude, look at me here,’” Newland told me. “‘Why don’t you just tell them I’m 16?’” But because certain pharmaceutical companies set certain age cutoffs for their clinical trial, she alone in her family can’t get a COVID-19 shot. She’s the only one who remains vulnerable. She’s the only one who has to quarantine from all her friends if she gets exposed. ....

United States , City Of , United Kingdom , Oliver Ratmann , Katherine Wu , Imperial College London , Landscape Of Covid 19 Risk , Bsolute Number Of Cases , 9 Year Old , Covid 19 Shot , Pharmaceutical Companies , Younger Kids , Accine Limbo , Teens Ages , Ow Risk Situation , Elderly Parents , Jk Schools , Unvaccinated Kids , Clinical Trial , Covid 19 Risk , Elative Share Of Cases , Imperial College London , Rural Residents , Dinner Party , 7 Year Old , Strange Relationship ,